| Vol. 14.01 – 14 January, 2022 |
| |
|
|
| The authors edited the TRAC locus in human peripheral blood T cells to engage cell-surface targets through their T cell receptor–CD3 complex reconfigured to utilize the same immunoglobulin heavy and light chains as a matched CAR. [Nature Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Using androgen receptor (AR) deficient and Foxp3 fate-mapping mice, researchers determined that AR signaling increased Treg suppression during Alternaria extract challenge by stabilizing Foxp3+ Tregs and limiting the number of ST2+ ex-Tregs and IL-13+ Th2 and ex-Tregs. [Journal of Clinical Investigation] |
|
|
|
| Both in vitro and in vivo Treg migration was effectively blocked by a novel, small molecule antagonist of CCR4, CCR4-351. [PLoS Pathogens] |
|
|
|
| Investigators showed that chemokine-like factor-like MARVEL transmembrane domain-containing family member 6 (CMTM6) was upregulated in clear cell renal cell carcinoma tissues and was strongly associated with advanced tumor grades, early metastases, and a worse prognosis. [Oncoimmunology] |
|
|
|
| The authors observed significantly fewer LAG-3+ CD4 and CD8 T cells from subjects with relapsing-remitting multiple sclerosis and type 1 diabetes. [Journal of Immunology] |
|
|
|
| Using a mouse model of sepsis, scientists found that the long noncoding RNA HOXA transcript antisense RNA myeloid-specific 1 (HOTAIRM1) was highly expressed in mice during the late phase of sepsis. [Journal of Immunology] |
|
|
|
| Investigators found that astilbin inhibited R837-induced maturation and activation of bone marrow-derived dendritic cells and decreased the expression of pro-inflammatory cytokines by downregulating myeloid differentiation factor 88. [Journal of Cellular and Molecular Medicine] |
|
|
|
| The authorss asked whether CCR2 was necessary for the development of colitis in mice lacking the receptor for IL10. [Scientific Reports] |
|
|
|
| Researchers revealed that nuclear receptor subfamily 4 Group A member 1 was upregulated during cardiac allograft rejection and that the increased Nr4A1 was primarily localized in intragraft-infiltrating CD4+ T cells. [International Immunopharmacology] |
|
|
|
| Scientists generated a therapeutic chimeric protein containing the PD-L1 single-chain variable fragment linked to a cleavable model cytotoxic T lymphocyte epitope: E7 CTL peptide. [Journal of Immunology Research] |
|
|
|
|
| The authors review the specific functions of several T cell populations involved in NAFLD and NAFLD-driven HCC. [Hepatology] |
|
|
|
| A considerable number of studies suggest that the role of indoleamine 2,3 dioxygenase in T helper 2 cell regulation may be different from that of T helper 1 immune responses. [Molecular Biology Reports] |
|
|
|
|
| Emerald Health Pharmaceuticals, Inc. received clearance of its Investigational New Drug (IND) application by the FDA to begin enrolling patients in its Phase IIa clinical trial of EHP-101 for certain relapsing forms of multiple sclerosis (MS), specifically relapsing-remitting MS and active secondary progressive MS. [Emerald Health Pharmaceuticals, Inc. (GlobeNewswire, Inc.)] |
|
|
|
| Researchers at University Health Network (UHN) and the University of Toronto (UoT) received $24 million to advance technology to repair and rebuild organs outside the body for patients in need. [University of Toronto] |
|
|
|
|
| February 6 – 10, 2022 Banff, Alberta, Canada |
|
|
|
|
|
| UK Research and Innovation – Oxfordshire, England, United Kingdom |
|
|
|
| National Institute of Health – Rockville, Maryland, United States |
|
|
|
| Fox Chase Cancer Center, Temple University – Philadelphia, Pennsylvania, United States |
|
|
|
| The University of Texas Southwestern Medical Center – Dallas, Texas, United States |
|
|
|
| Intima Bioscience – Cambridge, England, United Kingdom |
|
|
|
|